Unique gene expression profile based on pathologic response in epithelial ovarian cancer

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• Epithelial ovarian cancer (EOC) prognosis remains challenging.
• Identifying predictive biomarkers for treatment response is crucial.

Purpose of the Study:

• To determine if tumor gene expression at diagnosis predicts outcomes in EOC patients undergoing second-look surgery.
• To identify a gene signature associated with pathologic complete response.

Main Methods:

• Oligonucleotide microarrays were used to profile diagnostic tumor tissue.
• Class prediction analysis was performed on training and validation sets (24 and 36 patients, respectively).

Main Results:

• A 93-gene signature, the Chemotherapy Response Profile (CRP), was identified, predicting pathologic complete response.
• The CRP distinguished between favorable and unfavorable overall survival in the validation set (log-rank P = .007).
• The CRP maintained independent prognostic value and, when combined with the Ovarian Cancer Prognostic Profile (OCPP), improved prognostic discrimination.

Conclusions:

• A gene expression profile based on pathologic response in EOC provides independent prognostic information.
• The CRP offers potential insights into chemotherapy drug resistance mechanisms.
• Further research is underway to develop a tailored profile using genes from both CRP and OCPP.